Analyst says AcelRx Pharmaceuticals is undervalued By: MarketMinute.com Stock News July 17, 2017 at 17:55 PM EDT Hudson River Capital Research wrote that AcelRx Pharmaceuticals Inc. (Nasdaq: ACRX) was undervalued. The stock price rose 75 cents to close at $3.15. Related Stocks: Acelrx Pharmaceutica